This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Obstructive Sleep Apnea Syndrome
and you are
between 2 and 10
years old
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The aim of the project is to evaluate whether therapy with leukotriene may be a valid therapeutic approach in children with adenotonsillar hypertrophy and with mild and moderate obstructive sleep apnea syndrome (OSAS) and to evaluate whether leukotriene is less, equally or more efficient than nasal steroid.

Provided treatments

  • Drug: budesonide (Aircort 50 nasal spray)
  • Drug: montelukast (Singulair)
Tris trial is registered with FDA with number: NCT00912171. The sponsor of the trial is University of Bologna and it is looking for 45 volunteers for the current phase.
Official trial title:
Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome (OSAS) in Children